Insider Transactions in Q1 2020 at Ngm Biopharmaceuticals Inc (NGM)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
118,067
+9.27%
|
$1,416,804
$12.53 P/Share
|
|
Mar 25
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
2,416
+0.23%
|
$28,992
$12.49 P/Share
|
|
Mar 24
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
128,377
+11.03%
|
$1,540,524
$12.22 P/Share
|
|
Mar 23
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
170,387
+15.81%
|
$1,874,257
$11.63 P/Share
|
|
Mar 20
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
143,082
+16.26%
|
$1,573,902
$11.77 P/Share
|
|
Mar 19
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
148,464
+20.0%
|
$1,633,104
$11.59 P/Share
|
|
Mar 05
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
8,307
+1.83%
|
$149,526
$18.0 P/Share
|
|
Mar 04
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
9,986
+2.23%
|
$169,762
$17.96 P/Share
|
|
Mar 03
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
38,758
+8.32%
|
$658,886
$17.99 P/Share
|
|
Mar 02
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
14,124
+3.51%
|
$240,108
$17.9 P/Share
|
|
Feb 28
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
37,800
+9.17%
|
$642,600
$17.91 P/Share
|
|
Feb 27
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
33,896
+9.15%
|
$576,232
$17.91 P/Share
|
|
Feb 26
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
3,751
+1.22%
|
$67,518
$18.0 P/Share
|
|
Feb 06
2020
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
44,900
+13.06%
|
$673,500
$15.96 P/Share
|